Cookie Policy | UCB SpA in Motion

In this Cookie Policy, you will find information about the cookies used on [please insert URL of the Website], a website in relation to [please complete] (the Website). The Website is operated by [insert relevant UCB entity], a company with registered office at [insert address] (UCB, we or us).

This Cookie Policy applies to all webpages which form part of the Website.

Any personal data collected by UCB through cookies will be processed as set out in the [insert name] Privacy Policy, accessible here).

In this Cookie Policy, you will find more information on:

1. what cookies are and why UCB uses them;
2. the different types of cookies used on this Website.

To manage your cookie preferences, please visit the Privacy Preference Center, accessible at the bottom from every page of this Website. This Cookie Policy may be updated periodically. In that case, we will inform you of any significant changes by posting a prominent notice on the Website.

This educational platform has been initiated and funded by UCB Pharma B.V. and its affiliates.

Date of preparation: October 2022 BELU-N-DA-RH-2200037

For Norwegian participants:

Dette arrangementet arrangeres i samsvar med avtaler om samhandling som Legemiddelindustriforeningen har inngått med Den norske legeforening, Norges Farmaceutiske Forening, Norsk Sykepleierforbund og De regionale helseforetakene. For deg som helsepersonell medfører dette at både du og arrangøren har rettigheter og plikter som skal sikre at arrangementet er av god faglig kvalitet og at det ikke er egnet til å skape forestillinger om uheldige bindinger mellom industri og helsepersonell. For mer informasjon se LMIs nettsider.

For Swedish participants:

Den enskilde medarbetaren ansvarar för att inhämta godkännande från huvudman. Inbjudan skickas med kopia till huvudman.

Arrangemanget genomförs i samarbete med UCB Pharma AB, enligt gällande avtal mellan LIF och SKR. Deltagande i mötet kräver godkännande från klinikchef/verksamhetschef enligt gällande avtal mellan LIF och SKR.

Försändelsen är utsänd med stöd av uppgifter ur Hälso- och Sjukvårdens Adressregister, HSAR, av UCB Nordic A/S, som är ansluten till Integritetsskyddsprogrammet för HSAR. Ytterligare information om adressuppgifter och registrering erhålls via http://www.hsar.se/ eller av Cegedim AB, 08-6337680.

The website is neither intended nor designed to record or report adverse events. If you have adverse events to report for a UCB product, please follow the current regulatory procedure in force in your country or click on the following link to access the contact page of the UCB corporate website where you can report adverse events to us through local affiliate contacts, UCB Cares or the completion of the UCB AE webform. https://www.ucb.com/contact